Lyell Immunopharma Inc
NASDAQ:LYEL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Lyell Immunopharma Inc
NASDAQ:LYEL
|
US |
|
H
|
Husqvarna AB
XBER:HRZ
|
SE |
|
Tpximpact Holdings PLC
LSE:TPX
|
UK |
|
Derichebourg SA
PAR:DBG
|
FR |
|
Husqvarna AB
OTC:HSQVY
|
SE |
|
SBM Offshore NV
AEX:SBMO
|
NL |
|
MBIA Inc
NYSE:MBI
|
US |
|
Nusco SpA
MIL:NUS
|
IT |
|
Fajar Surya Wisesa Tbk PT
IDX:FASW
|
ID |
|
Colopl Inc
TSE:3668
|
JP |
|
Associated Banc-Corp
NYSE:ASB
|
US |
|
Kurita Water Industries Ltd
F:KWI0
|
JP |
|
Group 1 Automotive Inc
NYSE:GPI
|
US |
|
I
|
International Games System Co Ltd
TPEX:3293
|
TW |
|
M
|
Merck KGaA
XHAN:MRK
|
DE |
|
C
|
Chularat Hospital PCL
SET:CHG
|
TH |
|
Latham Group Inc
NASDAQ:SWIM
|
US |
|
H
|
HALEON PLC
XHAN:H6D0
|
UK |
|
B
|
Bayer AG
XHAN:BAYN
|
DE |
|
Kurita Water Industries Ltd
TSE:6370
|
JP |
|
Derichebourg SA
LSE:0K8W
|
FR |
|
Rogers Communications Inc
NYSE:RCI
|
CA |
|
Rogers Communications Inc
TSX:RCI.A
|
CA |
|
CY4GATE SpA
MIL:CY4
|
IT |
Bankruptcy Probability
Lyell Immunopharma Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Lyell Immunopharma Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Lyell Immunopharma Inc
NASDAQ:LYEL
|
302.6m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
465.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
209.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
164.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
122.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
73B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
48.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Lyell Immunopharma Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Lyell Immunopharma Inc has no debt.
You can find a full breakdown on its Balance Sheet.
